Denis Lacombe
Researcher Next ID · RN-029888
Researcher · Economics, Econometrics and Finance
European Organisation for Research and Treatment of Cancer
Brussels, Belgium
- Works count
- 163
- Citation count
- 67,947
- H-index
- 42
- i10-index
- 98
Research interests
Publications
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
The Lancet Oncology · 2016 · https://doi.org/10.1016/s1470-2045(16)30313-8
Imaging biomarker roadmap for cancer studies
Nature Reviews Clinical Oncology · 2016 · https://doi.org/10.1038/nrclinonc.2016.162
New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials
Neuro-Oncology · 2013 · https://doi.org/10.1093/neuonc/not117
Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma
Neurology · 2011 · https://doi.org/10.1212/wnl.0b013e31822f02e1
Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy
JNCI Journal of the National Cancer Institute · 2009 · https://doi.org/10.1093/jnci/djn460
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
The Lancet Oncology · 2009 · https://doi.org/10.1016/s1470-2045(09)70025-7
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
European Journal of Cancer · 2008 · https://doi.org/10.1016/j.ejca.2008.10.026
Phase II Study of Imatinib in Patients With Recurrent Gliomas of Various Histologies: A European Organisation for Research and Treatment of Cancer Brain Tumor Group Study
Journal of Clinical Oncology · 2008 · https://doi.org/10.1200/jco.2008.16.9235
Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3
The Lancet Oncology · 2007 · https://doi.org/10.1016/s1470-2045(07)70384-4
Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma: Recursive Partitioning Analysis of the EORTC 26981/22981-NCIC CE3 Phase III Randomized Trial
Journal of Clinical Oncology · 2006 · https://doi.org/10.1200/jco.2005.04.5963
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
New England Journal of Medicine · 2005 · https://doi.org/10.1056/nejmoa043330
Current projects
No projects listed.